Phibro Animal Health Corporation (PAHC)

Phibro Animal Health Corporation (PAHC) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $34.92, down 0.29% on the day, which values the company at $1.42B. Price as of 18 Nov 2026, 12:30 UTC, from Yahoo Finance.

Key facts

Share price
$34.92−0.29% today
Market value
$1.42B
P/E ratio
13.9×last 12 months
Forward P/E
9.0×
Dividend yield
1.37%
Funk Score
54/100
Against its own history
Below its usual priceusual price $45.52
200-week average
$25.1339% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Phibro Animal Health Corporation in more detail

PAHC trades at 13.9× its last twelve months' earnings, 9.0× next year's expected earnings, 0.9× sales. Measured against its own history, the price is 23% below what its usual multiples would imply ($45.52) — below its usual price. It sits 39% above its 200-week average of $25.13.

Over the last five fiscal years Phibro Animal Health Corporation has compounded revenue 12.7% a year, earnings per share 12.6% a year, free cash flow -12.3% a year. Its Funk Score is 54 out of 100 (financial strength 4.1, profitability 5.6, growth 6.3, value 5.8, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Share count keeps rising; Dividend is not covered by free cash flow.

Phibro Animal Health Corporation (PAHC): questions and answers

What is PAHC's P/E ratio?

Phibro Animal Health Corporation trades at 13.9× its last twelve months' earnings and 9.0× next year's expected earnings. At its fiscal year-ends over the past 12 years the P/E ranged from 9.0× to 279.5×, with a median of 22.3×.

What is PAHC's PEG ratio?

Phibro Animal Health Corporation's PEG ratio is 1.68 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Phibro Animal Health Corporation's market cap?

Phibro Animal Health Corporation is valued at $1.42B at a share price of $34.92.

Is PAHC overvalued or undervalued?

Against its own history, PAHC is below its usual price: the price is 23% below the $45.52 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is PAHC above its 200-week moving average?

Yes. PAHC is 39.0% above its 200-week average of $25.13. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Phibro Animal Health Corporation growing?

Over the last five fiscal years Phibro Animal Health Corporation's revenue grew 12.7% a year and its earnings per share 12.6% a year; over ten years revenue grew 7.3% a year.

Cite this page

Funkfolio, “Phibro Animal Health Corporation (PAHC) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/PAHC

Underlying data: Yahoo Finance; company filings with the SEC.